Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1996 61
1997 55
1998 60
1999 67
2000 97
2001 106
2002 102
2003 86
2004 117
2005 119
2006 141
2007 174
2008 177
2009 159
2010 202
2011 246
2012 235
2013 239
2014 228
2015 278
2016 240
2017 304
2018 390
2019 633
2020 323
Text availability
Article attribute
Article type
Publication date

Search Results

4,416 results
Results by year
Filters applied: . Clear all
Page 1
Intratumoral Immunotherapy-Update 2019.
Hamid O, Ismail R, Puzanov I. Hamid O, et al. Oncologist. 2019 Nov 29:theoncologist.2019-0438. doi: 10.1634/theoncologist.2019-0438. Online ahead of print. Oncologist. 2019. PMID: 31784490 Free article. Review.
Follicular Lymphoma: Recent and Emerging Therapies, Treatment Strategies, and Remaining Unmet Needs.
Matasar MJ, Luminari S, Barr PM, Barta SK, Danilov AV, Hill BT, Phillips TJ, Jerkeman M, Magagnoli M, Nastoupil LJ, Persky DO, Okosun J. Matasar MJ, et al. Oncologist. 2019 Nov;24(11):e1236-e1250. doi: 10.1634/theoncologist.2019-0138. Epub 2019 Jul 25. Oncologist. 2019. PMID: 31346132 Free PMC article. Review.
Lenvatinib in Management of Solid Tumors.
Hao Z, Wang P. Hao Z, et al. Oncologist. 2019 Oct 14:theoncologist.2019-0407. doi: 10.1634/theoncologist.2019-0407. Online ahead of print. Oncologist. 2019. PMID: 31611332 Free article. Review.
Radiofrequency Ablation and Microwave Ablation in Liver Tumors: An Update.
Izzo F, Granata V, Grassi R, Fusco R, Palaia R, Delrio P, Carrafiello G, Azoulay D, Petrillo A, Curley SA. Izzo F, et al. Oncologist. 2019 Oct;24(10):e990-e1005. doi: 10.1634/theoncologist.2018-0337. Epub 2019 Jun 19. Oncologist. 2019. PMID: 31217342 Free PMC article. Review.
Sicca Syndrome Associated with Immune Checkpoint Inhibitor Therapy.
Warner BM, Baer AN, Lipson EJ, Allen C, Hinrichs C, Rajan A, Pelayo E, Beach M, Gulley JL, Madan RA, Feliciano J, Grisius M, Long L, Powers A, Kleiner DE, Cappelli L, Alevizos I. Warner BM, et al. Oncologist. 2019 Sep;24(9):1259-1269. doi: 10.1634/theoncologist.2018-0823. Epub 2019 Apr 17. Oncologist. 2019. PMID: 30996010 Free PMC article.
FDA Approval Summary: Ruxolitinib for Treatment of Steroid-Refractory Acute Graft-Versus-Host Disease.
Przepiorka D, Luo L, Subramaniam S, Qiu J, Gudi R, Cunningham LC, Nie L, Leong R, Ma L, Sheth C, Deisseroth A, Goldberg KB, Blumenthal GM, Pazdur R. Przepiorka D, et al. Oncologist. 2019 Oct 22:theoncologist.2019-0627. doi: 10.1634/theoncologist.2019-0627. Online ahead of print. Oncologist. 2019. PMID: 31641064 Free article.
Cabozantinib Versus Sunitinib for Untreated Patients with Advanced Renal Cell Carcinoma of Intermediate or Poor Risk: Subgroup Analysis of the Alliance A031203 CABOSUN trial.
George DJ, Hessel C, Halabi S, Michaelson MD, Hahn O, Walsh M, Picus J, Small EJ, Dakhil S, Feldman DR, Mangeshkar M, Scheffold C, Morris MJ, Choueiri TK. George DJ, et al. Oncologist. 2019 Nov;24(11):1497-1501. doi: 10.1634/theoncologist.2019-0316. Epub 2019 Aug 9. Oncologist. 2019. PMID: 31399500 Free PMC article.
Analysis of DNA Damage Response Gene Alterations and Tumor Mutational Burden Across 17,486 Tubular Gastrointestinal Carcinomas: Implications for Therapy.
Parikh AR, He Y, Hong TS, Corcoran RB, Clark JW, Ryan DP, Zou L, Ting DT, Catenacci DV, Chao J, Fakih M, Klempner SJ, Ross JS, Frampton GM, Miller VA, Ali SM, Schrock AB. Parikh AR, et al. Oncologist. 2019 Oct;24(10):1340-1347. doi: 10.1634/theoncologist.2019-0034. Epub 2019 Apr 30. Oncologist. 2019. PMID: 31040255 Free PMC article.
4,416 results
Jump to page
Feedback